Master protocol for metastatic hormone-resistant prostatic carcinoma - phase II trials - protocol 5: Capecitabine
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Jun 2019 Biomarkers information updated
- 08 Jun 2007 New trial record.